List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 48 studies with search of: antibody[TREATMENT] AND ("non-hodgkin's lymphoma" [CONDITION] OR CLL [CONDITION]) | Open Studies
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant for Non-Hodgkin Lymphoma
Conditions: Adult Non-Hodgkin Lymphoma;   Anaplastic Large-Cell Lymphoma;   Contiguous Stage II Adult Diffuse Large Cell Lymphoma;   Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma;   Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma;   Contiguous Stage II Grade 1 Follicular Lymphoma;   Contiguous Stage II Grade 2 Follicular Lymphoma;   Contiguous Stage II Grade 3 Follicular Lymphoma;   Contiguous Stage II Mantle Cell Lymphoma;   Lymphoma, Small Cleaved-Cell, Follicular;   Lymphoma, Mixed-Cell, Follicular;   Lymphoma, Large-Cell, Follicular;   Mantle Cell Lymphoma;   Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma;   Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma;   Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma;   Noncontiguous Stage II Grade 1 Follicular Lymphoma;   Noncontiguous Stage II Grade 2 Follicular Lymphoma;   Noncontiguous Stage II Grade 3 Follicular Lymphoma;   Noncontiguous Stage II Mantle Cell Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult T-cell Leukemia/Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Stage I Adult Diffuse Large Cell Lymphoma;   Stage I Adult Diffuse Mixed Cell Lymphoma;   Stage I Adult Diffuse Small Cleaved Cell Lymphoma;   Stage I Adult T-cell Leukemia/Lymphoma;   Stage I Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage I Grade 1 Follicular Lymphoma;   Stage I Grade 2 Follicular Lymphoma;   Stage I Grade 3 Follicular Lymphoma;   Stage I Mantle Cell Lymphoma;   Stage I Mycosis Fungoides/Sezary Syndrome;   Stage II Adult T-cell Leukemia/Lymphoma;   Stage II Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage II Mycosis Fungoides/Sezary Syndrome;   Stage III Adult Diffuse Large Cell Lymphoma;   Stage III Adult Diffuse Mixed Cell Lymphoma;   Stage III Adult Diffuse Small Cleaved Cell Lymphoma;   Stage III Adult T-cell Leukemia/Lymphoma;   Stage III Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage III Grade 1 Follicular Lymphoma;   Stage III Grade 2 Follicular Lymphoma;   Stage III Grade 3 Follicular Lymphoma;   Stage III Mantle Cell Lymphoma;   Stage III Mycosis Fungoides/Sezary Syndrome;   Stage IV Adult Diffuse Large Cell Lymphoma;   Stage IV Adult Diffuse Mixed Cell Lymphoma;   Stage IV Adult Diffuse Small Cleaved Cell Lymphoma;   Stage IV Adult T-cell Leukemia/Lymphoma;   Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage IV Grade 1 Follicular Lymphoma;   Stage IV Grade 2 Follicular Lymphoma;   Stage IV Grade 3 Follicular Lymphoma;   Stage IV Mantle Cell Lymphoma;   Stage IV Mycosis Fungoides/Sezary Syndrome
Interventions: Drug: rituximab;   Drug: carmustine;   Drug: cytarabine;   Drug: etoposide;   Drug: melphalan;   Drug: bortezomib;   Drug: vorinostat;   Procedure: autologous hematopoietic stem cell transplantation
2 Recruiting Iodine I 131 Monoclonal Antibody BC8 and Autologous Stem Cell Transplant in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Treatment
Condition: Lymphoma
Interventions: Procedure: autologous hematopoietic stem cell transplantation;   Radiation: iodine I 131 monoclonal antibody BC8
3 Recruiting Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: therapeutic immune globulin;   Drug: busulfan;   Drug: fludarabine phosphate;   Procedure: allogeneic hematopoietic stem cell transplantation
4 Recruiting T Lymphocytes and Anti-CD45 Monoclonal Antibody in Treating Patients With Relapsed Epstein-Barr Virus-Associated Hodgkin Lymphoma, Non-Hodgkin Lymphoma, or Lymphoproliferative Disorders
Conditions: Lymphoma;   Lymphoproliferative Disorder
Interventions: Biological: anti-CD45 monoclonal antibody;   Biological: autologous LMP1-/LMP2- specific cytotoxic T-lymphocytes;   Genetic: polymerase chain reaction;   Other: flow cytometry;   Other: immunoenzyme technique
5 Recruiting Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease
Conditions: Leukemia;   Non-Hodgkin's Lymphoma;   NHL
Interventions: Drug: Immunotoxin therapy;   Drug: CAT-8015 Immunotoxin;   Procedure: Biological therapy;   Procedure: Antibody Therapy;   Procedure: Monoclonal Antibody Therapy
6 Recruiting Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies
Conditions: Non-Hodgkin's Lymphoma;   Chronic Lymphocytic Leukemia
Intervention: Drug: hLL1
7 Recruiting Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Precancerous/Nonmalignant Condition;   Viral Infection
Interventions: Other: cytology specimen collection procedure;   Other: fluorescent antibody technique;   Procedure: assessment of therapy complications
8 Recruiting Bevacizumab and AZD2171 in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma
Conditions: Brain and Central Nervous System Tumors;   Lymphoma;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: bevacizumab;   Drug: cediranib maleate;   Genetic: TdT-mediated dUTP nick end labeling assay;   Other: flow cytometry;   Other: fluorescent antibody technique;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: biopsy;   Procedure: dynamic contrast-enhanced magnetic resonance imaging
9 Recruiting FCR and Bevacizumab in the Treatment of Relapsed CLL
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Rituximab;   Drug: Bevacizumab
10 Recruiting Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment
Condition: Non-Hodgkin Lymphoma
Interventions: Drug: Rituximab;   Drug: Epratuzumab
11 Recruiting Monoclonal Antibody Therapy in Treating Patients With T-Cell Large Granular Lymphocyte Leukemia
Condition: Leukemia
Intervention: Biological: monoclonal antibody Mik-beta-1
12 Recruiting The Humanized Monoclonal Antibody Milatuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: Milatuzumab
13 Recruiting Autologous T Lymphocytes Engrafted With a Chimeric Antigen Receptor Targeting the Kappa Light Chain
Conditions: Chronic Lymphocytic Leukemia (B-CLL);   B Cell Non-Hodgkin Lymphoma (B-NHL)
Intervention: Biological: Genetically modified T cells
14 Recruiting Evaluation of Patients Who Have Skin Diseases
Conditions: Lymphoma;   Melanoma (Skin)
Interventions: Genetic: polymerase chain reaction;   Other: electron microscopy;   Other: flow cytometry;   Other: fluorescent antibody technique;   Other: immunoenzyme technique;   Other: immunohistochemistry staining method;   Other: microscopy;   Procedure: biopsy;   Procedure: radiography
15 Recruiting Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Procedure: computed tomography;   Procedure: positron emission tomography;   Procedure: radionuclide imaging;   Procedure: single photon emission computed tomography;   Radiation: tositumomab and iodine I 131 tositumomab;   Radiation: yttrium Y 90 ibritumomab tiuxetan
16 Recruiting Monoclonal Antibody IMC-A12 and Temsirolimus in Treating Patients With Locally Advanced or Metastatic Cancer
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Precancerous/Nonmalignant Condition;   Sarcoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: cixutumumab;   Drug: temsirolimus
17 Recruiting Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine Therapy
Condition: Lymphoma
Intervention: Biological: ipilimumab
18 Recruiting A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma;   Follicular Lymphoma;   Diffuse Large Cell Lymphoma
Intervention: Drug: Iodine I 131 Tositumomab Therapeutic Regimen
19 Recruiting Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Leukemia;   Lymphoma
Interventions: Drug: alvocidib;   Drug: lenalidomide;   Genetic: protein expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: fluorescent antibody technique;   Other: immunoenzyme technique;   Other: laboratory biomarker analysis;   Other: pharmacological study
20 Recruiting Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: therapeutic autologous lymphocytes;   Drug: carmustine;   Drug: cytarabine;   Drug: etoposide;   Drug: melphalan;   Procedure: peripheral blood stem cell transplantation

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services